###begin article-title 0
###xml 118 126 <span type="species:ncbi:9606">Patients</span>
A Single Nucleotide Polymorphism within the Acetyl-Coenzyme A Carboxylase Beta Gene Is Associated with Proteinuria in Patients with Type 2 Diabetes
###end article-title 0
###begin p 1
Conceived and designed the experiments: SM YN. Performed the experiments: SM MaK MI TY HU HDS KSP. Analyzed the data: SM BIF DPKN TT HDS KSP. Contributed reagents/materials/analysis tools: SiA TB BIF MAB JNC MT TU LT TH PG AJ DPKN KK MI DS HDS KSP AK YI KK RK HHP DWB OP. Wrote the paper: SM BIF TH OP. Performed real-time PCR: MK TY. Performed transfection experiments: MK HU. Performed European American study: BIF MAB JNC DWB. Performed Danish Type 1 diabetes study: LT AJ HHP. Performed Danish Steno-2 study: TH PG OP. Performed Singapore study: DPKN. Performed in situ hybridization: MI. Performed Korean study: HDS KSP.
###end p 1
###begin p 2
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 479 481 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1100 1102 1100 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 1267 1269 1267 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 1428 1436 1428 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1760 1765 1760 1765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
###xml 791 799 <span type="species:ncbi:9606">patients</span>
###xml 913 921 <span type="species:ncbi:9606">patients</span>
###xml 1058 1066 <span type="species:ncbi:9606">patients</span>
###xml 1560 1565 <span type="species:ncbi:9606">human</span>
###xml 1837 1845 <span type="species:ncbi:9606">patients</span>
It has been suggested that genetic susceptibility plays an important role in the pathogenesis of diabetic nephropathy. A large-scale genotyping analysis of gene-based single nucleotide polymorphisms (SNPs) in Japanese patients with type 2 diabetes identified the gene encoding acetyl-coenzyme A carboxylase beta (ACACB) as a candidate for a susceptibility to diabetic nephropathy; the landmark SNP was found in the intron 18 of ACACB (rs2268388: intron 18 +4139 C > T, p = 1.4x10-6, odds ratio = 1.61, 95% confidence interval [CI]: 1.33-1.96). The association of this SNP with diabetic nephropathy was examined in 9 independent studies (4 from Japan including the original study, one Singaporean, one Korean, and two European) with type 2 diabetes. One case-control study involving European patients with type 1 diabetes was included. The frequency of the T allele for SNP rs2268388 was consistently higher among patients with type 2 diabetes and proteinuria. A meta-analysis revealed that rs2268388 was significantly associated with proteinuria in Japanese patients with type 2 diabetes (p = 5.35x10-8, odds ratio = 1.61, 95% Cl: 1.35-1.91). Rs2268388 was also associated with type 2 diabetes-associated end-stage renal disease (ESRD) in European Americans (p = 6x10-4, odds ratio = 1.61, 95% Cl: 1.22-2.13). Significant association was not detected between this SNP and nephropathy in those with type 1 diabetes. A subsequent in vitro functional analysis revealed that a 29-bp DNA fragment, including rs2268388, had significant enhancer activity in cultured human renal proximal tubular epithelial cells. Fragments corresponding to the disease susceptibility allele (T) had higher enhancer activity than those of the major allele. These results suggest that ACACB is a strong candidate for conferring susceptibility for proteinuria in patients with type 2 diabetes.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 521 529 <span type="species:ncbi:9606">patients</span>
Although cumulative epidemiological findings have suggested that genetic susceptibility plays an important role in the pathogenesis of diabetic nephropathy, no gene conferring susceptibility to diabetic nephropathy has been definitively identified. In a large-scale association study of 1,312 Japanese subjects with type 2 diabetes using SNPs from a Japanese SNP database, we show that the T-allele of ACACB rs2268388 is associated with diabetic nephropathy. We also show that the association is consistently observed in patients with type 2 diabetes and proteinuria across different ethnic groups, including populations of European descent. Because a DNA fragment corresponding to the disease susceptibility allele is shown to have higher enhancer activity, we hypothesize that the increase in the expression and/or activity of the encoded acetyl-coenzyme A carboxylase beta contributes to the development and progression of diabetic nephropathy. Our present analysis provides novel insight into the pathogenesis of diabetic nephropathy. This finding is important because diabetic nephropathy is a leading cause of end-stage renal disease and affects life expectancy in subjects with type 2 diabetes.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 95 98 95 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-U1">[1]</xref>
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Nakai1">[2]</xref>
###xml 576 579 576 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Seaquist1">[3]</xref>
###xml 580 583 580 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Quinn1">[4]</xref>
###xml 180 188 <span type="species:ncbi:9606">patients</span>
Diabetic nephropathy is a leading cause of end-stage renal disease (ESRD) in Western countries [1] and in Japan [2]. The rising incidence of diabetic nephropathy, especially among patients with type 2 diabetes, is a serious worldwide concern in terms of both poor prognosis and medical costs. The pathogenesis of diabetic nephropathy has not been fully elucidated. However, susceptibility to diabetic nephropathy appears to be determined by multiple genetic and environmental risk factors, and genetic susceptibility plays an important role in its development and progression [3],[4].
###end p 6
###begin p 7
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Freedman1">[5]</xref>
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Maeda1">[6]</xref>
###xml 688 691 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Frayling1">[7]</xref>
###xml 692 695 692 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Prokopenko1">[8]</xref>
###xml 706 709 706 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Unoki1">[9]</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Yasuda1">[10]</xref>
###xml 1150 1154 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Pezzolesi1">[11]</xref>
###xml 443 448 <span type="species:ncbi:9606">human</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Both candidate gene approaches and genome-wide linkage analyses have suggested several candidate genes with potential impact on diabetic nephropathy. However, these findings have not been robustly replicated [5],[6], and many susceptibility genes for diabetic nephropathy remain to be identified. The recent development of single nucleotide polymorphism (SNP) typing technology and insights into patterns of linkage disequilibrium (LD) in the human genome have facilitated genome-wide association studies (GWASs) for investigating genes associated with disease susceptibility across the entire human genome. GWASs conducted by several independent research groups in Europe, United States [7],[8] and Japan [9],[10] have identified multiple loci associated with susceptibility to common complex traits, including type 2 diabetes. Recently conducted GWAS in a population of European descent identified 4 distinct loci associated with diabetic nephropathy in type 1 diabetes. Two of these loci were replicated in a population of the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) cohorts [11].
###end p 7
###begin p 8
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Haga1">[12]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Hirakawa1">[13]</xref>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC12A3</italic>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Tanaka1">[14]</xref>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELMO1</italic>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Shimazaki1">[15]</xref>
###xml 510 515 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NCALD</italic>
###xml 528 532 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Kamiyama1">[16]</xref>
###xml 602 607 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELMO1</italic>
###xml 661 665 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Leak1">[17]</xref>
###xml 689 693 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Pezzolesi2">[18]</xref>
###xml 419 422 <span type="species:ncbi:9606">Man</span>
With the aim of identifying loci involved in susceptibility to common diseases, we initiated a large-scale association study using SNPs from a Japanese SNP database (JSNP: ) [12],[13], that was established before creation of the HapMap database. Through this project, we have previously identified genes encoding solute carrier family 12 (sodium/chloride) member 3 (SLC12A3: MIM 600968, Online Mendelian Inheritance in Man: )[14], engulfment and cell motility 1 (ELMO1: MIM 606420)[15], and neurocalcin delta (NCALD: MIM 606722)[16] as being associated with susceptibility to diabetic nephropathy. The ELMO1 association has been replicated in African Americans [17] and European Americans [18].
###end p 8
###begin p 9
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 268 276 <span type="species:ncbi:9606">patients</span>
In the present study, we extended a previous large-scale association study for diabetic nephropathy, and provide evidence that a SNP within the acetyl-coenzyme A (CoA) carboxylase beta gene (ACACB; MIM: 601557) contributes to an increased prevalence of proteinuria in patients with type 2 diabetes across different ethnic populations.
###end p 9
###begin title 10
Results
###end title 10
###begin p 11
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 354 356 354 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 424 431 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000842-t001">Table 1</xref>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
We extended our prior analysis to SNPs with p values between 0.01 and 0.05, and examined the association of these SNPs with diabetic nephropathy in a larger study sample. In this analysis, a SNP within ACACB showed the strongest association with diabetic nephropathy in Japanese patients with type 2 diabetes (rs2268388: intron 18 +4139 C > T, p = 1.4x10-6, odds ratio [OR]  = 1.61, 95% confidence interval [Cl]: 1.33-1.96, Table 1).
###end p 11
###begin title 12
Top 4 SNPs associated with diabetic nephropathy in a genome-wide screening.
###end title 12
###begin p 13
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</sup>
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>(a)</sup></bold>
(a)minor allele frequencies are shown, and genotype counts are in parenthesis.
###end p 13
###begin p 14
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</sup>
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>(b)</sup></bold>
(b)p values for Hardy Weinberg equilibrium test.
###end p 14
###begin p 15
###xml 259 264 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 271 287 269 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000842-g001">Figure 1A and 1B</xref>
###xml 319 324 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 463 468 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 613 622 611 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000842-g001">Figure 1C</xref>
###xml 624 632 622 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000842.s004">Table S1</xref>
###xml 746 755 744 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000842.s001">Figure S1</xref>
Subsequent LD mapping around this region with data for 264 SNPs with allele frequencies >/=0.1 from HapMap database (HapMap: ) for the Japanese, identified a 20-kb LD block that included an original marker SNP (rs2268388), which corresponded to a part of the ACACB gene (Figure 1A and 1B). Therefore, we concluded that ACACB was likely a candidate for conferring susceptibility to diabetic nephropathy. We next analyzed 51 SNPs, including 31 tagging SNPs, within ACACB in our Japanese population (Japanese1). Several SNPs within the same LD block as rs2268388 were nominally associated with diabetic nephropathy (Figure 1C, Table S1). No single SNP or haplotype showed stronger association with diabetic nephropathy than the original marker SNP (Figure S1).
###end p 15
###begin title 16
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
Schematic view of the association of SNPs in the ACACB region with diabetic nephropathy.
###end title 16
###begin p 17
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 528 530 528 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
(A) Pairwise correlation structure at a 200-kb interval around SNP rs2268338 analyzed by Haploview (Haploview: ). The plot includes pairwise r2 values from the HapMap release 24 for the JPT population. (B) Genes located at this locus. The asterisk indicates the SNP rs2268388 at intron 18 of the ACACB. (C) Results of a case-control association study for diabetic nephropathy in 754 Japanese individuals with type 2 diabetes having overt proteinuria and 558 control individuals with type 2 diabetes and normoalbuminuria. The log10-transformed p values for an additive model are plotted on the Y-axis. The X-axis indicates chromosomal position at this locus.
###end p 17
###begin p 18
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000842-t002">Table 2</xref>
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 433 435 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
###xml 792 800 <span type="species:ncbi:9606">patients</span>
###xml 823 831 <span type="species:ncbi:9606">patients</span>
###xml 910 918 <span type="species:ncbi:9606">patients</span>
To validate the association of this SNP with diabetic nephropathy, we examined the effects of the SNP on susceptibility to the disease in several independent populations from different ethnic groups (Table 2). The results indicated that the frequency of the T allele of rs2268388 was consistently higher among patients with type 2 diabetes with proteinuria (combined meta-analysis gave a p value of 5.35x10-8 in the Japanese, 2.34x10-7 for all populations). Significant association with ESRD was detected in the relatively large European 2 samples (481 cases and 427 controls). The SNP was also modestly associated with ESRD in East Asian type 2 diabetes, but the direction of association differed. Overall, the distribution of the genotype for rs2268388 did not differ significantly between patients with ESRD and control patients having type 2 diabetes (p = 0.47). No significant association was detected in patients with type 1 diabetes having proteinuria.
###end p 18
###begin title 19
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
Association of the SNP in the ACACB (rs2268388) with diabetic nephropathy in several independent cohorts.
###end title 19
###begin p 20
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</sup>
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>(a)</sup></bold>
(a)Japanese 1; case-control for a genome-wide association study.
###end p 20
###begin p 21
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b)</sup>
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>(b)</sup></bold>
(b)risk allele frequencies are shown, and genotype counts are in parenthesis.
###end p 21
###begin p 22
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c)</sup>
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>(c)</sup></bold>
###xml 3 4 3 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(c)p values for additive model.
###end p 22
###begin p 23
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(d)</sup>
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>(d)</sup></bold>
(d)combined results by using Mantel-Haenszel test.
###end p 23
###begin p 24
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 194 203 194 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000842-g002">Figure 2A</xref>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acacb</italic>
###xml 363 372 363 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000842-g002">Figure 2B</xref>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
###xml 428 433 <span type="species:ncbi:9606">human</span>
We next examined the expression profile of ACACB in various human tissues. Expression of ACACB was observed in adipose tissue, heart and skeletal muscle, and, to a lesser extent, in the kidney (Figure 2A). The results of in situ hybridization with normal mouse kidney revealed that Acacb was localized to glomerular epithelial cells and tubular epithelial cells (Figure 2B). We also observed the expression of ACACB in cultured human renal proximal tubular epithelial cells (hRPTECs).
###end p 24
###begin title 25
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
Expression profiles of ACACB.
###end title 25
###begin p 26
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 101 108 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acacb</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
(A) Expression profiles of ACACB in various human tissues evaluated by real-time PCR. (B) Results of in situ hybridization for 20-week-old normal mouse kidneys using mouse Acacb anti-sense (left) and sense (right) probes.
###end p 26
###begin p 27
###xml 210 218 210 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000842-g003">Figure 3</xref>
###xml 669 678 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000842-g003">Figure 3B</xref>
To investigate the functional role of this SNP region, we examined the effects of a 29-bp DNA fragment containing the associated SNP (rs2268388) on transcriptional activity in cultured hRPTECs. As shown in the Figure 3, the 29-bp DNA fragments had significant enhancer activity (promoter alone [P]: 39.4+/-13.1; susceptibility allele [T]: 384.3+/-104.1; major allele [C]: 238.5+/-81.9; relative luciferase activity, p = 0.0005 for P vs. T, p = 0.016 for P vs. C). Fragments corresponding to the disease susceptibility allele had stronger enhancer activity than those for the major allele ([T] 10.5+/-3.4 vs. [C] 5.9+/-1.3, fold increase over promoter alone, p = 0.045, Figure 3B).
###end p 27
###begin title 28
Effect of a 29-bp DNA fragment containing the associated SNP (rs2268388) on transcriptional activity in cultured hRPTECs.
###end title 28
###begin p 29
###xml 181 186 <span type="species:ncbi:9606">human</span>
(A) A 29-bp sequence including SNP rs2268338. Overhung sequences are compatible ends for concatenation. (B) Enhancer activities of the DNA fragments corresponding to each allele in human RPTECs. Results are shown as mean +/- SD of the ratio of activity to that of the promoter alone obtained from 4 independent experiments. * p = 0.045 vs. major allele.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
In the present study, we showed ACACB located at chromosome 12q24.1 to be a strong susceptibility gene for diabetic nephropathy in patients with type 2 diabetes. Our findings suggest that a SNP within ACACB (rs2268388, intron 18 + 4139 C > T) contributes to the development of proteinuria in patients with type 2 diabetes.
###end p 31
###begin p 32
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CPT1A</italic>
###xml 372 377 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acacb</italic>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-AbuElheiga1">[19]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Oh1">[21]</xref>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 643 648 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 892 896 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-AbuElheiga3">[22]</xref>
###xml 918 923 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 959 966 959 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 995 1000 995 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acacb</italic>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Kume1">[23]</xref>
###xml 1150 1154 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Wahba1">[24]</xref>
###xml 359 363 <span type="species:ncbi:10090">Mice</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
###xml 1096 1101 <span type="species:ncbi:10090">mouse</span>
ACACB encodes acetyl-coenzyme A (CoA) carboxylase beta, which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, and controls fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine palmitoyl transferase I (CPT1A; MIM 600528), the rate-limiting step in fatty acid uptake and oxidation by mitochondria in non-lipogenic tissues. Mice lacking Acacb have a normal life span, a higher rate of fatty acid oxidation, lower amounts of fat, and increased insulin sensitivity [19]-[21]; therefore, ACACB might affect insulin sensitivity via modulation of fatty acid metabolism. However evidence suggesting a role for the ACACB in the pathogenesis of diabetic nephropathy was previously lacking. In this study, expression of ACACB was detected in heart, skeletal muscle and adipose tissues by real-time quantitative polymerase chain reaction (PCR) as previously reported [22]. We also showed that ACACB was expressed in human kidney, and in situ hybridization revealed that Acacb expression was localized to glomerular epithelial cells and tubular epithelial cells in normal mouse kidneys. Abnormalities in lipid metabolism [23],[24], including fatty acid metabolism have been shown to contribute to the development and/or progression of chronic kidney diseases, including diabetic nephropathy. Hence, genotype-based differences in expression and/or activity of this enzyme in the kidney might contribute to conferring susceptibility to diabetic nephropathy.
###end p 32
###begin p 33
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 447 452 <span type="species:ncbi:9606">human</span>
Elucidating these functional differences will help us to understand how variation in this gene contributes to susceptibility to diabetic nephropathy. In this study, the 29-bp fragment that included the landmark SNP (rs2268388) was shown to have significant enhancer activity. We also demonstrated that the DNA corresponding to the disease susceptibility allele had significantly higher enhancer activity than that for the major allele in cultured human RPTECs. Therefore, the intronic variation in the gene seems to be causal. We hypothesize that higher expression of ACACB in the kidneys of subjects having the disease susceptibility allele (T) may increase the susceptibility to diabetic nephropathy in type 2 diabetes.
###end p 33
###begin p 34
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Krolewski1">[25]</xref>
###xml 708 715 708 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000842-t002">Table 2</xref>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 805 813 <span type="species:ncbi:9606">patients</span>
Interestingly, the association of the T allele of rs2268388 with type 2 diabetes-associated nephropathy was consistently observed in cases with proteinuria, whereas there was less consistent association between type 2 diabetic patients under chronic renal replacement therapy (ESRD). Discrepancies in genomic loci underlying susceptibility to proteinuria versus ESRD were previously noted in a genome-wide linkage scan for diabetic nephropathy in type 2 diabetes [25]. Because most of the patients with ESRD were considered to have had proteinuria, and there is significant heterogeneity in the association with diabetic ESRD among the East Asian and European American populations (heterogeneity p = 0.0006, Table 2), some selection bias, such as a survival effect, or ethnic differences might exist when patients with ESRD were used as cases. Since the presence of proteinuria is also recognized as a predictor of cardio-vascular diseases, the association of ACACB with proteinuria might reflect an association between the gene and cardio-vascular diseases or metabolic syndrome. However elucidation of a precise mechanism will require further investigation.
###end p 34
###begin p 35
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
###xml 409 417 <span type="species:ncbi:9606">patients</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 825 833 <span type="species:ncbi:9606">patients</span>
Association of the ACACB with diabetic nephropathy could not be replicated in patients with type 1 diabetes, although these nephropathy cases had proteinuria. The clinical features or histological characteristics of diabetic nephropathy are similar in both type1 and type 2 diabetes mellitus; however, there are some differences in the background circumstances between both types of the disease. For example, patients with type 2 diabetes are generally older, and more obese than those with type 1 diabetes. Therefore, it is possible that genetic factors for nephropathy are different for type 1 and type 2 diabetes, although some overlap may exist. Because the statistical power of this study for patients with type 1 diabetes was probably not sufficient, the association of variations in ACACB with diabetic nephropathy in patients with type 1 diabetes should be re-evaluated in future studies.
###end p 35
###begin p 36
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Pezzolesi1">[11]</xref>
Recently, GWASs have been performed to identify susceptibility genes for common diseases. Convincing susceptibility genes for many diseases including type 2 diabetes have been successfully identified by GWASs. A GWAS for diabetic nephropathy was conducted in the Genetics of Kidneys in Diabetes (GoKinD) collection, and several novel loci were identified for diabetic nephropathy in type 1 diabetes [11]. Compared to our study, recent GWASs conducted in European and American groups had greater power to detect true associations. The power of the first and second test in the present study is estimated >40% and >90% respectively, for SNPs with minor allele frequency of 0.2 as in our sample, if we set a cut-off value at the p = 0.05 level, a genotypic relative risk (gamma) of 1.5, and the prevalence of diabetic nephropathy is assumed to be 10% (CaTS power calculator, CaTS: ). Therefore, other important loci contributing to diabetic nephropathy in Japanese populations may not have been detected and should be searched for using a larger scale of GWAS. Limitations exist in increasing the numbers of subjects with diabetic nephropathy and diabetes lacking nephropathy in single center studies. Therefore, we examined several independently collected study populations, allowing for the presence of different selection criteria and the small sample size in some replication cohorts. Future analyses should attempt to avoid these limitations so as not to produce spurious results.
###end p 36
###begin p 37
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
In summary, based upon extensive genome-wide gene-centric SNP analyses, we identified ACACB as a candidate gene for conferring susceptibility to diabetic nephropathy. Subsequent replication studies in several different ethnic groups and a functional study suggest that the T-allele of a common intronic SNP (rs2268338) within ACACB is a risk factor for the development and progression of proteinuria in patients with type 2 diabetes.
###end p 37
###begin title 38
Materials and Methods
###end title 38
###begin title 39
Subjects, DNA preparation, and genotyping
###end title 39
###begin p 40
###xml 1318 1322 1306 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Tanaka1">[14]</xref>
###xml 1323 1327 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Kamiyama1">[16]</xref>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 209 214 <span type="species:ncbi:9606">Women</span>
###xml 575 583 <span type="species:ncbi:9606">patients</span>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
###xml 903 911 <span type="species:ncbi:9606">patients</span>
###xml 1109 1116 <span type="species:ncbi:9606">patient</span>
Japanese 1 (genome-wide screening); DNA samples were obtained from the peripheral blood of patients with type 2 diabetes who regularly attended outpatient clinics at Shiga University of Medical Science, Tokyo Women's Medical University, Juntendo University, Kawasaki Medical School, Iwate Medical University, Toride Kyodo Hospital, Kawai Clinic, Osaka City General Hospital, Chiba Tokusyukai Hospital or Osaka Rosai Hospital. All subjects provided informed consent before enrolling in this study. DNA extraction was performed by a standard phenol-chloroform method. Diabetic patients were divided into 2 groups according to the following diagnostic criteria: 1) nephropathy cases, i.e., patients with diabetic retinopathy and overt nephropathy, indicated by a urinary albumin excretion rate (AER) >/=200 microg/min or a urinary albumin/creatinine ratio (ACR) >/=300 mg/g creatinine (Cr), and 2) control patients who have diabetic retinopathy but no evidence of renal dysfunction (i.e. AER less than 20 microg/min or ACR less than 30 mg/g Cr). Measurements of AER or ACR were performed at least twice for each patient. The SNPs for genotyping were randomly selected from our gene-based Japanese SNP (JSNP) database. The genotype of each SNP locus was analyzed with multiplex PCR-invader assays, as described previously [14]-[16].
###end p 40
###begin p 41
###xml 457 466 457 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000842.s002">Figure S2</xref>
###xml 737 746 737 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000842.s003">Figure S3</xref>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Our first screening involved genotyping 94 nephropathy cases and 94 control patients for more than 100,000 SNP loci. In total, 76,767 SNP loci, which distributed to 13,707 gene-centric regions and covered approximately 35% of common SNPs (MAF >0.15) in these regions, were successfully genotyped by the invader assay (success rates >0.95). We estimated identity by descent (IBD) sharing to assess relatedness among our initial GWAS populations. As shown in Figure S2, the result indicates that there were no close relative pairs in this population. We also performed principal component analysis (PCA) using our initial GWAS populations to evaluate population structures. Since all subjects were in a single cluster in the PCA analysis (Figure S3), no evidence for population stratification between case and control groups appeared to exist in the present GWAS.
###end p 41
###begin p 42
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Tanaka1">[14]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Kamiyama1">[16]</xref>
###xml 257 265 <span type="species:ncbi:9606">patients</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
After the first round of analysis that evaluated SNPs with p values less than 0.01 in the first screening (previously published [14]-[16]), we extended our analysis to include SNPs with p values between 0.01 and 0.05 and examined them in a larger number of patients (754 nephropathy cases vs. 558 control patients). The study protocol was approved by the ethics committees of RIKEN Yokohama Institute and each participating institution.
###end p 42
###begin title 43
Subjects in replication studies
###end title 43
###begin title 44
Japanese replication studies
###end title 44
###begin p 45
We obtained DNA samples from 2 longitudinal studies (Japanese 2, Japanese 3) and one case-control study (Japanese 4).
###end p 45
###begin p 46
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Araki1">[26]</xref>
###xml 563 568 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 12 20 <span type="species:ncbi:9606">Patients</span>
###xml 72 84 <span type="species:ncbi:9606">participants</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
Japanese 2; Patients with type 2 diabetes were recruited from among the participants in the Shiga Prospective Observational Follow-Up Study for Diabetic Complications [26]. On the basis of at least 2 measurements of AER in 24-h urine collections, those classified as having microalbuminuria (200 microg/min > AER >/=20 microg/min) were followed for up to 6 years. The progressors (cases) were defined as those had progressed to overt proteinuria (AER >/=200 microg/min, n = 32), and the remaining patients were defined as non-progressors (controls, n = 168). The ACACB genotype was analyzed with multiplex PCR-invader assays. The study protocol and informed consent procedure were approved by the ethics committee of Shiga University of Medical Science.
###end p 46
###begin p 47
###xml 414 418 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Nishiyama1">[27]</xref>
###xml 637 642 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 12 20 <span type="species:ncbi:9606">Patients</span>
###xml 464 472 <span type="species:ncbi:9606">patients</span>
###xml 571 579 <span type="species:ncbi:9606">patients</span>
###xml 704 712 <span type="species:ncbi:9606">patients</span>
Japanese 3; Patients with type 2 diabetes and normoalbuminuria or microalbuminuria, as determined by at least two measurements of ACR or AER (normoalbuminuria; ACR <30 mg/g Cr or AER <20 microg/min, microalbuminuria; 30</= ACR <300 mg/g Cr or 20</= AER <200 microg/min) who could be followed for 10 years were recruited from among diabetic outpatients at Juntendo University Hospital or Saiseikai Central Hospital [27]. Progressors (cases, n = 71) were defined as patients who progressed from a given stage to a more advanced stage of diabetic nephropathy; the remaining patients were defined as non-progressors (controls, n = 193). The ACACB genotype was analyzed with multiplex PCR-invader assays. All patients gave informed consent and the protocol was approved by the ethics committee of Juntendo University or that of Saiseikai Central Hospital.
###end p 47
###begin p 48
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 12 20 <span type="species:ncbi:9606">Patients</span>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 433 441 <span type="species:ncbi:9606">Patients</span>
Japanese 4; Patients with type 2 diabetes regularly visiting Tokai University Hospital or its affiliated hospitals were enrolled. All nephropathy cases were receiving chronic hemodialysis therapy (n = 300), and control patients were those with normoalbuminuria determined by at least 2 measurements of the urinary ACR, and diabetes for more than 10 years (n = 218). The ACACB genotype was analyzed with multiplex PCR-invader assays. Patients gave informed consent and the protocol was approved by the ethics committee of Tokai University School of Medicine.
###end p 48
###begin title 49
Korean replication study
###end title 49
###begin p 50
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Kim1">[28]</xref>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 521 522 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
###xml 385 393 <span type="species:ncbi:9606">patients</span>
###xml 839 846 <span type="species:ncbi:9606">patient</span>
Korean patients with type 2 diabetes comprising two groups according to the following criteria were examined [28]: 1) the control group (n = 196): patients with diabetic retinopathy and who had diabetes for more than 15 years but no renal involvement (i.e., ACR<30 mg/g Cr and creatinine clearance [using the Cockroft equation] of >60 ml/min per 1.73 m2); 2) the ESRD group (n = 177): patients with diabetic retinopathy and ESRD due to type 2 diabetes, as indicated by a creatinine clearance rate of <15 ml/min per 1.73 m2 or receiving renal replacement therapy. The TaqMan method for genotyping was applied in the Korean replication study. The institutional review board of the Clinical Research Institute at Seoul National University Hospital approved the study protocol, and informed consent for genetic analysis was obtained from each patient.
###end p 50
###begin title 51
Singaporean replication study
###end title 51
###begin p 52
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Ng1">[29]</xref>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 175 183 <span type="species:ncbi:9606">Patients</span>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
Cases and controls were selected from Chinese patients with type 2 diabetes who had been enrolled into the Singapore Diabetes Cohort Study (SDCS) as previously reported [29]. Patients with ACR >300 mg/g Cr or dipstick positive were considered nephropathy cases (n = 199). Controls were patients who were normalbuminuric with ACR <30 mg/g Cr and had diabetes for more than 7 years (n = 212). The ACACB genotype was analyzed using a Taqman genotyping assay available from Applied Biosystems (Foster city, CA, U.S.A.). The research protocol for SDCS was approved by both the National University of Singapore Institutional Review Board (NUS-012) and the National Healthcare Group Domain-Specific Review Board (C/05/118).
###end p 52
###begin title 53
European replication studies
###end title 53
###begin p 54
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Gaede1">[30]</xref>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 22 30 <span type="species:ncbi:9606">Patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">Patients</span>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
###xml 535 547 <span type="species:ncbi:9606">participants</span>
European 1 (Steno 2): Patients were recruited from the Steno Diabetes Center between 1992 and 1993. Microalbuminuria was defined as an AER of 30-300 mg per 24 h in 4 of 6 samples of sterile urine. These patients were enrolled and followed up for an average of 7.8 years [30]. Patients who progressed to nephropathy (AER >300 mg per 24 h, n = 47) were used as cases, and the remaining patients were defined as controls (n = 110). The ACACB genotype was analyzed with multiplex PCR-invader assays. Informed consent was obtained from all participants. The protocol was in accordance with the Declaration of Helsinki and was approved by the ethics committee of Copenhagen County.
###end p 54
###begin p 55
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 26 34 <span type="species:ncbi:9606">Patients</span>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
European 2 (Wake Forest): Patients with European ancestry who were born in North Carolina, South Carolina, Georgia, Tennessee, or Virginia were enrolled. Cases all had type 2 diabetes mellitus for 5 or more years before the development of ESRD with overt proteinuria and/or diabetic retinopathy (n = 481). Control patients had type 2 diabetes for more than 5 years with ACR <30 mg/g Cr and serum creatinine <1.5 mg/dl (n = 427). The ACACB SNP was genotyped using the MassARRAY genotyping system (Sequenom, San Diego, CA, U.S.A.). PCR primers were designed using the MassARRAY Design 3.4 Software (Sequenom). This study was conducted under Institutional Review Board approval from Wake Forest University School of Medicine, and adhered to the tenets of the Declaration of Helsinki.
###end p 55
###begin p 56
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Jorsal1">[31]</xref>
###xml 898 903 892 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 246 254 <span type="species:ncbi:9606">Patients</span>
###xml 790 798 <span type="species:ncbi:9606">patients</span>
###xml 1087 1095 <span type="species:ncbi:9606">patients</span>
Type 1 diabetes: Adults with type 1 diabetes attending the outpatient clinic at the Steno Diabetes Center were invited to participate in a study of genetic risk factors for the development of diabetic micro- and macrovascular complications [31]. Patients were considered to have type 1 diabetes if the age at onset of diabetes was </=35 years and if the time to definitive insulin therapy was </=1 year. Established diabetic nephropathy (cases, n = 458) was defined as persistent albuminuria (>/=300 mg/24 h) in 2 out of 3 consecutive measurements on sterile urine in the presence of retinopathy. The absence of diabetic nephropathy (controls, n = 442) was defined as persistent normoalbuminuria (urinary albumin excretion rate: <30 mg/24 h) after at least 15 years of diabetes duration in patients not treated with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers. The ACACB genotype was analyzed with multiplex PCR-invader assays. The study was performed in accordance with the Declaration of Helsinki. The local ethics committee approved the study and all patients gave their informed consent.
###end p 56
###begin p 57
###xml 69 77 69 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000842.s005">Table S2</xref>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
The clinical characteristics of patients in all studies are shown in Table S2.
###end p 57
###begin title 58
Real-time quantitative RT-PCR
###end title 58
###begin p 59
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 169 202 169 202 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGG ATG CGT AAC TTC GAT CTG-3&#8242;</named-content>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BACT</italic>
###xml 265 300 265 300 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">- TCA CCC ACA CTG TGC CCA TCT ACG A</named-content>
###xml 318 353 318 353 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">- CAG CGG AAC CGC TCA TTG CCA ATG G</named-content>
###xml 898 902 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BACT</italic>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 892 897 <span type="species:ncbi:9606">human</span>
We obtained human cDNAs from multiple tissues from CLONTECH Inc. (Palo Alto, CA, U.S.A.). The cDNAs were amplified by PCR with the following primers: human ACACB, sense 5'-CGG ATG CGT AAC TTC GAT CTG-3', antisense 5'-CTA TGG TCC GTC ACT TCC ACA C-3'; BACT, sense 5'- TCA CCC ACA CTG TGC CCA TCT ACG A -3', antisense 5'- CAG CGG AAC CGC TCA TTG CCA ATG G -3'. Amplification was performed in a 22 microl reaction volume that contained 1x EX Taq Buffer, 200 nM dNTP, 1/20,000 SYBR Green, 0.2 microM Rox, 800 nM gene-specific primer, 0.05 U/microl EX Taq Hot Start Version (Takara, Otsu, Japan), and 5 ng of template DNA. The thermal profile was 50degreesC for 2 min, at 95degreesC for 10 min, followed by 40 cycles at 95degreesC for 30 s and at 60degreesC for 60 s in thermal cycler (Mx3000P Multiplex Quantitative PCR system; Stratagene, La Jolla, CA, U.S.A.). The results were normalized with human BACT.
###end p 59
###begin title 60
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
In situ hybridization
###end title 60
###begin p 61
###xml 658 665 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 760 764 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Shimazaki1">[15]</xref>
###xml 852 857 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acacb</italic>
###xml 895 900 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acacb</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 941 946 <span type="species:ncbi:10090">mouse</span>
Under pentobarbital anesthesia, 20-week-old mice were flushed with PBS through the abdominal aorta followed by perfusion with 4% paraformaldehyde buffered with PBS (pH 7.4). The kidneys were quickly removed and cut into small pieces. The renal cortex tissue was immediately dissected and immersed into a fresh portion of the same fixative at 4degreesC overnight. All steps were carefully carried out to avoid contamination with RNase. Diethylpyrocarbonate-treated water was used at 0.1% to prepare each buffer. The fixed samples were thoroughly rinsed with PBS (pH 7.4) and subsequently dehydrated by passage through an alcohol series and cleared in xylene. In situ hybridization was performed on paraffin-embedded sections using a previously described method [15]. Antisense and sense single-strand cRNAs were synthesized from cDNA fragments encoding Acacb using reverse-transcription PCR. The Acacb cDNA fragment was consisted of a 500 bp mouse sequence (nucleotides 181-680, GenBank accession number NM_133904, GenBank: ).
###end p 61
###begin title 62
Plasmid construction and transfection experiments
###end title 62
###begin p 63
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 264 269 <span type="species:ncbi:9606">human</span>
Three copies of the 29-bp DNA fragments including rs2268388 in ACACB were subcloned into a pGL3-promoter vector (Promega, Madison, WI, U.S.A.) at its multi-cloning site upstream of the SV-40 promoter. We introduced constructs corresponding to each allele into the human renal proximal tubular epithelial cells (hRPTEC, Lonza, Basel, Switzerland) along with a sea-pansy luciferase control vector, pRL-TK (Promega), using the liposome transfection procedure (Lipofectoamine 2000, Life Technology Inc, Carlsbad, CA, U.S.A.). Twenty-four hours after transfection, luciferase activitiy was determined by means of the Dual Luciferase Reporter Assay System (Promega). The luminescence of firefly luciferase was corrected by use of the sea-pansy luciferase, which reflected transfection efficiency.
###end p 63
###begin title 64
Statistical analyses
###end title 64
###begin p 65
###xml 112 113 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 119 123 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Nielsen1">[32]</xref>
###xml 161 162 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 187 191 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Devlin1">[33]</xref>
###xml 456 461 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACACB</italic>
###xml 616 620 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000842-Sladek1">[34]</xref>
We tested the genotype and allele frequencies for Hardy-Weinberg equilibrium (HWE) proportions by use of the chi2 test [32]. We calculated the LD index, D' and r2, as described elsewhere [33]. We analyzed the differences between the case and control groups with regard to the genotype distribution and allele frequency in the genome-wide screen by Fisher's exact test with dominant, recessive and allelic models with autosomal SNPs. The association of the ACACB locus with diabetic nephropathy in the replication study was evaluated with the Armitage test for trends using an additive model, as described previously [34]. Combined meta-analysis was performed by using the Mantel-Haenszel procedure with a fixed effect model after testing for heterogeneity. The data from the transfection experiments were analyzed by one-way analysis of variance, followed by Scheffe's test to evaluate statistical differences among 3 groups or by an un-paired t test to evaluate differences between 2 groups.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
Haplotype frequencies and the association of haplotypes in the ACACB with diabetic nephropathy. Fifty-one SNPs within the ACACB were genotyped in 754 nephropathy cases and 558 controls. Nine haplotype blocks are identified using Gabriel's Method by Haploview.
###end p 67
###begin p 68
(0.58 MB EPS)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
Estimation of IBD sharing among subjects in the genome-wide screening.
###end p 70
###begin p 71
(0.24 MB EPS)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
Quality control for the genome-wide screening. (A) Principal Compornent Analysis (PCA) (B) quantile-quantile plot.
###end p 73
###begin p 74
(0.42 MB EPS)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
Association of SNPs in the ACACB gene with diabetic nephropathy in Japanese subjects with type 2 diabetes. (A) tagging SNPs to cover this locus are shown in bold. (B) Minor allele frequencies are presented. Genotype counts are in parenthesis. 11; homozygous for major allele, 12; heterozygous, 22; homozygous for minor allele. (C) p values for the additive model.
###end p 76
###begin p 77
(0.14 MB DOC)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
Clinical characteristics of the subjects. Values are mean +/- SE, NA: not available. (A) Data at baseline are presented. (B) 5 unknown. (C) 6 unknown. (D) p<0.05 versus control.
###end p 79
###begin p 80
(0.09 MB DOC)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 47 55 <span type="species:ncbi:9606">patients</span>
We thank all participating doctors, staff, and patients from the collaborating institutes for providing DNA samples. We thank Mr. Takashi Morizono at Laboratory for Medical Informatics, RIKEN Center for Genomic Medicne, for contributing to a quality control of the present GWAS. We also thank the technical staff of the Laboratory for Endocrinology and Metabolism at the RIKEN Center for Genomic Medicine for providing technical assistance.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Overview of Regular Dialysis Treatment in Japan as of 31 December 2006.
###end article-title 84
###begin article-title 85
Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.
###end article-title 85
###begin article-title 86
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Familial factors determine the development of diabetic nephropathy in patients with IDDM.
###end article-title 86
###begin article-title 87
Genetic factors in diabetic nephropathy.
###end article-title 87
###begin article-title 88
Genetics of diabetic nephropathy Ther Adv Cardiovasc Dis
###end article-title 88
###begin article-title 89
Genome-wide association studies provide new insights into type 2 diabetes aetiology.
###end article-title 89
###begin article-title 90
Type 2 diabetes: new genes, new understanding.
###end article-title 90
###begin article-title 91
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.
###end article-title 91
###begin article-title 92
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus.
###end article-title 92
###begin article-title 93
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.
###end article-title 93
###begin article-title 94
###xml 128 133 <span type="species:ncbi:9606">human</span>
Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism.
###end article-title 94
###begin article-title 95
JSNP: a database of common gene variations in the Japanese population.
###end article-title 95
###begin article-title 96
Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms.
###end article-title 96
###begin article-title 97
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELMO1</italic>
Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.
###end article-title 97
###begin article-title 98
Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy.
###end article-title 98
###begin article-title 99
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELMO1</italic>
Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans.
###end article-title 99
###begin article-title 100
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ELMO1</italic>
Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Support its Role as a Susceptibility Gene in Diabetic Nephropathy.
###end article-title 100
###begin article-title 101
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
###end article-title 101
###begin article-title 102
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets.
###end article-title 102
###begin article-title 103
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice.
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms.
###end article-title 104
###begin article-title 105
Peroxisome proliferator-activated receptors in diabetic nephropathy.
###end article-title 105
###begin article-title 106
Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
###end article-title 106
###begin article-title 107
A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes.
###end article-title 107
###begin article-title 108
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes.
###end article-title 108
###begin article-title 109
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC12A3</italic>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study.
###end article-title 109
###begin article-title 110
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC12A3</italic>
SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy.
###end article-title 110
###begin article-title 111
Reduced glomerular filtration rate and albuminuria in type 2 diabetes mellitus are both independently associated with activation of the TNF-alpha system.
###end article-title 111
###begin article-title 112
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
###end article-title 112
###begin article-title 113
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.
###end article-title 113
###begin article-title 114
Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus.
###end article-title 114
###begin article-title 115
A comparison of linkage disequilibrium measures for fine-scale mapping.
###end article-title 115
###begin article-title 116
A genome-wide association study identifies novel risk loci for type 2 diabetes.
###end article-title 116
###begin p 117
The authors have declared that no competing interests exist.
###end p 117
###begin p 118
This work was partly supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The Singapore study was supported by the Singapore National Medical Research Council (NMRC/1018/2005). The Danish study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention, and Care (LUCAMP). The European American study was supported by NIH Grants RO1 DK53591 (DWB) and RO1 DK70941 (BIF). The Korean study was supported by a grant from the Korea Health 21 R & D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea (00-PJ3-PG6-GN07-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 118

